
==== Front
Rev Cardiovasc Med
Rev Cardiovasc Med
RCM
Reviews in Cardiovascular Medicine
1530-6550
2153-8174
IMR Press

10.31083/j.rcm2508278
S1530-6550(24)01412-1
Review
Pullback Pressure Gradient—An Emerging Concept in Patients with Coronary Artery Disease
Omari Muntaser 1
Ibrahem Abdalazeem 1
Bawamia Bilal 1
Cartlidge Timothy 1
Bagnall Alan 1
Purcell Ian 1
Egred Mohaned 1
Zaman Azfar 1 2
Farag Mohamed 1
Alkhalil Mohammad 1 2 * mohammad.alkhalil@nhs.net

Servi Stefano De Academic Editor
1Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK
2Translational and Clinical Research Institute, Newcastle University, NE1 7RU Newcastle-upon-Tyne, UK
*Correspondence: mohammad.alkhalil@nhs.net (Mohammad Alkhalil)
7 8 2024
8 2024
25 8 2786 3 2024
30 3 2024
8 4 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY 4.0 license.
Fractional flow reserve fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) is currently recommended in the management of patients with stable coronary artery disease (CAD). Pullback pressure gradient (PPG) index is an emerging concept that provides a fully quantitative measure of the longitudinal distribution of CAD. It can be derived from FFR, as well as other non-hyperemic indices, and is a novel metric of assessing the focality or diffuseness of CAD. PPG adds a second domain to the assessment of CAD, beyond ischemia as measured by FFR, and may enable clinicians to better inform their patients about the status of their CAD but may also predict potential outcomes before revascularization. In this article, we will provide an in-depth review on the concept of PPG index and its correlation to pre and post revascularization ischemia. We will assess the relationship between PPG index and plaque characteristics and how this is translated into any difference in procedural and long-term clinical outcomes.

coronary artery disease
physiology
pressure wire
pullback pressure gradient
diffuse
focal
ischemia
symptoms
clinical outcomes
==== Body
pmc1. Introduction

Myocardial revascularisation with either percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery is indicated when there is documentation of significant obstruction to coronary blood flow associated with myocardial ischemia in patients for whom medical therapy has failed or is expected to lead to suboptimal outcomes [1]. Current guidelines recommend the use of invasive physiological assessment of coronary lesions to guide revascularization [1, 2]. This is particularly important for patients with intermediate coronary stenoses, whereby the accuracy of invasive coronary angiography alone in predicting the hemodynamic significance of coronary stenosis is less than 50% [1, 2].

Fractional flow reserve (FFR) is a well-established method to invasively assess coronary ischemia and appear to improve clinical outcomes when guiding percutaneous coronary revascularization [3, 4]. Non-invasive assessment of coronary ischemia using quantitative flow ratio (QFR) as well as invasive resting indices are also recognised methods to detect ischemia and to guide percutaneous coronary revascularization [5, 6, 7]. FFR has shown to be a useful tool in guiding treatment or for risk stratification in complex clinical as well as anatomical subsets of patients undergoing coronary revascularization. This includes patients with acute coronary syndrome (ACS), impaired left ventricle function, women, renal disease, and diabetes [8, 9, 10, 11, 12, 13]. On the other hand, patients with serial lesions may render physiological assessment of coronary lesions more challenging [14]. The interaction among serial coronary lesions is well-established in the literature and often resulted in underestimating the hemodynamic significance of coronary lesions [14, 15, 16, 17, 18, 19, 20]. A study by Kim et al. [14] highlighted that true FFR was lower than apparent FFR in the proximal and distal lesions; with a significant pressure step-up of a non-primary target lesion after stenting the primary target lesion [14, 19, 20]. Therefore, better characterization of coronary anatomy would add further insights into the role of ischemia assessment in patients with coronary artery disease (CAD). An emerging concept has recently been proposed to allow better evaluation of coronary anatomy. Pullback pressure gradient (PPG) index was introduced to provide a quantitative metric of patterns of CAD [17, 21]. This review article provides an overview of this concept, its relation to ischemia, and potential future role in the management of patients with CAD.

2. Patterns of Coronary Artery Disease

The anatomical distribution of atherosclerotic CAD was early recognized using both invasive and non-invasive imaging modalities [22, 23]. Terms such as focal or diffuse CAD are well-established in clinical practice and have been linked to patients clinical outcomes. When compared head-to-head, the prevalence and the extent of CAD patters were not similar using various imaging modalities [22, 23]. In fact, invasive coronary angiography systematically underestimated the presence and distribution of CAD when compared to computed tomography (CT) and intra-vascular ultrasound (IVUS) [22, 23]. Diffuse CAD was detected on IVUS in patients with angiography normal coronary arteries [20, 24]. Overall, the accuracy of using coronary angiography in classifying patterns of CAD into focal, diffuse, or combined was very modest with significant inter-observer variability when assessing advanced coronary stenoes [21].

There is a well-established relationship between patterns of CAD and clinical outcomes following coronary revascularization [25, 26]. Patients with diffuse disease have higher rate of left internal mammary artery graft failure and poor prognosis in those undergoing CABG [27]. Similalrly, performing PCI produced less clinical benefits in patients with diffuse compared to focal coronary stenoses [26]. Therefore, patients with diffuse CAD are increasingly managed conservatively [21]. Notably, there is no angiographic consensus on the definition of CAD patterns, challenging any attempts to standardize clinical management in these patients.

Previous studies have highlighted the change in distal coronary pressure during pullback manoeuvre of the sensor mounted on the guidewire [24, 28]. Pressure loses along the coronary artery are related to numerous variables, including the presence of epicardial stenosis, length of the lesion, plaque features and their impact on laminar flow and viscous friction [24, 25, 26, 28, 29, 30]. Collectively, these factors would influence coronary pressure and produce a map of their integrated effects on pressure loses as well as epicardial resistance. Interestingly, mild epicardial coronary resistance was present in early stages of coronary atherosclerosis and was translated into myocardial ischaemia on positron emission tomography (PET) prior to segmental coronary stenosis on coronary angiography [24, 31]. The ability to standardise the relationship between changes in pressure over the length of the coronary artery would provide a functional assessment of the distribution of CAD. It may also overcome the current limitations of using coronary angiography for anatomical assessment of CAD patterns.

3. The Concept of PPG

The integrated effects of plaque characteristics and flow patterns are not static features and change over the length of the coronary artery. Accurate evaluation of the correspondent changes in pressure loses in relation to the distribution of atherosclerosis requires steady pullback of the guidewire which was accomplished using motorized FFR pullback [21, 32]. This technique provided a new term of FFR drop, which allowed better understanding of the contribution of diffuse and/or focal CAD during pullback manoeuvre. By combining the magnitude of pressure drop alongside the extent of CAD, defined as the functional decrease in pressure over the entire length of the coronary artery, a new metric was devised to enable precise assessment of the spatial distribution of CAD [21]. PPG index is derived from FFR pullback using the above two factors of maximal pressure drop over 20 mm of the length of the coronary artery (functional magnitude of the disease) and the entire pressure drop of the full length of the coronary artery (functional extent of the disease) (Fig. 1). It provides a fully quantitative and more reproducible measure of the patterns of CAD compared to coronary angiography. PPG index can be established using manual pullback with excellent intra- and interobserver reproducibility [33].

Fig. 1. Pullback pressure gradient calculation. MaxPPG, maximum pullback pressure gradient; ΔFFR, The decrease in fractional flow reserve (FFR) after adenosine administration from baseline FFR value.

In a proof-of-concept study PPG index reclassified more than one third of CAD patterns compared to coronary angiography [17, 21]. This reclassification was predominately from anatomical focal disease to combined or diffuse CAD. PPG index could be considered as a spectrum, that ranges from zero to one, to assess the focality or diffuseness of CAD, whereby the higher the index, the more focal the stenosis. Furthermore, PPG index allowed better characterization of patients with serial coronary lesions. These patients exhibited three distinct functional patterns related to the number of pressure drop during pullback manoeuvre [32]. PPG index not only was the highest among those patients with two focal pressure drops, but was able to independently predict the presence of this functional pattern among patients with diffuse CAD [32]. Such feature may assist with the suitability of coronary revascularization in patients with serial coronary lesions and help guiding coronary revascularization strategies in patients with various CAD patterns.

4. PPG Index and Ischemia

Several studies assessed the relationship between PPG index and coronary ischemia, measured using FFR [21, 34, 35]. Prior to PCI, there was an apparent disconnect between baseline FFR and PPG index [21, 34, 35]. In the validation study by Collet et al. [21] patients with the lowest tertile of PPG index also had the lowest FFR, despite having the most severe diameter stenosis [17]. A subsequent multicentre study highlighted that patients with focal lesions had lower FFR value which corresponded to a larger degree of diameter stenosis. The cohort of patients in the latter study were divided into two groups using a cut-off of >0.73 to define focal CAD [31, 35]. Using the same cut-off Ohashi et al. [34] reinforced this inconsistency between baseline FFR and PPG index [30]. In this randomised trial, patients with diffuse CAD who were assigned to FFR-guided PCI optimization strategy had lower pre-PCI FFR value compared to those with focal disease. In contrast, those with diffuse CAD who were assigned to standard practice had higher pre-PCI FFR compared to focal CAD. Of interest, across the three studies, the left anterior descending artery (LAD) was consistently less likely to demonstrate focal CAD pattern. This is unlikely to be related to an inherent pathophysiological process but directly linked to pressure loss phenomenon over the length of the LAD and its subsequent impact on measuring PPG index [25, 29].

Intuitively, the higher the PPG index, the more likely the potential gain in correcting epicardial resistance and achieving higher FFR post PCI. Recent studies have confirmed that patients with focal disease, defined as PPG index >0.73, achieved higher post PCI FFR compared to those with diffuse disease (0.91 ± 0.07 versus 0.86 ± 0.05, p < 0.001) [34, 35]. There was a relatively modest correlation between PPG index and post PCI FFR, highlighting CAD pattern as an additional mechanism of sub-optimal FFR results post PCI [30, 31, 32, 34, 35, 36]. Other mechanisms include sub-optimal stent results (under-expansion, edge dissection) and significant residual plaque burden outside the stented segment causing residual pressure gradient [34, 37]. Unsurprisingly, stent optimization had little value in relation to post PCI FFR in patients with diffuse disease [30, 34].

The change or delta FFR in response to PCI was also related to PPG index. Patients with focal disease had higher delta FFR compared to those with diffuse disease (0.33 ± 0.14 versus 0.17 ± 0.12, p < 0.001) [34, 35]. Importantly, the change in FFR was largely determined by PPG index at baseline (R2 = 0.51, p < 0.001). This provides important clinical information that may guide clinical management, including insights into symptomatic relief and clinical outcomes post PCI. A combined data from Fractional Flow Reserve vs Angiography for Multivessel Evaluation (FAME) and FAME 2 with available pre- and post PCI FFR highlighted a significant association between symptomatic relief and delta FFR [34, 38]. Moreover, patients with delta FFR in the lowest tertile had twice the events rate of vessel oriented clinical outcomes compared to those with highest tertile [hazard ratio, 2.01] [95% confidence interval (1.03–3.92); p = 0.04] [34, 38].

The change in coronary flow reserve (CFR) post PCI followed the same patterns as the change in FFR in relation to PPG index [30, 34]. The delta CFR in patients with diffuse CAD was of smaller magnitude compared to patients with focal CAD following PCI [30, 34]. Additionally, the reduction in index microcirculatory resistance (IMR) following PCI was also of smaller magnitude in patients with diffuse compared to focal disease and final IMR was numerically, but not statistically, higher in patients with diffuse disease [30, 34]. Whether these changes at the level of microcirculation are related to plaque characteristics, beyond the role of residual disease in patients with diffuse CAD, warrant further studies.

5. PPG Index and Atherosclerotic Plaque Characteristics

The interplay between CAD patterns, vessel hemodynamic and their impacts on plaque features were early recognized [35, 36, 37, 39, 40, 41]. The variations in local pressure gradient and its effect on laminar flow and wall shear stress is a recognised factor in the development and progression of coronary atherosclerotic plaque [37, 41]. Previous studies have shown that FFR was associated with vulnerable plaque and patients with lower FFR had more prevalent silent ruptured plaques [42, 43]. Nonetheless, direct evaluation of the impact of pressure loses on plaque characteristics was limited given the lack of longitudinal hemodynamic assessment on changes in plaque morphology.

The advent of PPG index allowed direct assessment of the regional relationship between plaque morphology and CAD patterns [40, 44]. Plaque burden, quantified across the entire coronary artery, was significantly higher in patients with diffuse disease compared to those with focal pattern (defined according to PPG index) [40, 44]. However, at the level of the minimal lumen area, this relationship was reversed and patients with diffuse CAD pattern had smaller plaque burden compared to individuals with focal disease [40, 44]. Likewise, there was a variation in plaque composition according to CAD patterns, as well as plaque volume. Using CT to characterise atherosclerotic plaque, patients with diffuse disease had more prevalent calcified plaques, whilst patients with focal CAD pattern had lower attenuation and non-calcified plaques [40, 44]. Invasive imaging modalities with optical coherence tomography (OCT) also revealed differential plaque characteristics in those with focal versus diffuse disease [44, 45]. Two studies revealed an association between high-risk plaque features and CAD patterns according to PPG index. The extent of lipid circumferential distribution was higher in patients with focal disease [40, 41]. The prevalence of thin-cap fibro-atheroma was also higher in patients with focal compared to diffuse disease [40, 41]. Finally, there was an inverse relationship between the thickness of fibrous cap and PPG index which translated into higher proportion of plaque ruptures in those with focal compared with diffuse disease [40, 41]. Such a differential relationship between CAD patterns and plaque morphology is also evident when assessing coronary hemodynamic. Metrics of shear wall stress were significantly higher in patients with focal compared to diffuse disease [41, 45]. Moreover, the combination of focal disease with high focal pressure gradient and high shear wall stress may synergistically contribute to destabilising plaque leading to acute plaque rupture and subsequent clinical events [41, 45].

Table 1. Features of coronary artery disease according to the pullback pressure gradient.

	Low PPG index	High PPG index	
Invasive coronary angiography	Diffuse disease	Focal disease	
	More likely with LAD	Less likely with LAD	
Ischemia using FFR	Various at baseline	Various at baseline	
	Low FFR post revascularization	High FFR post revascularization	
	Delta FFR is of smaller magnitude	Delta FFR is of larger magnitude	
Plaque burden	Large across the entire vessel	Small across the entire vessel	
	Small at MLA level	Large at MLA level	
Plaque characteristics	Calcified	Low-attenuation and non-calcified	
	Low circumferential lipid distribution	High circumferential lipid distribution	
Plaque stability	TCFA and sites of ruptured plaques less prevalent	TCFA and site of ruptured plaques more prevalent	
Symptoms	Less benefits following revascularization	More benefits following revascularization	
FFR, fractional flow reserve; LAD, left anterior descending artery; MLA, minimal lumen area; PPG, pullback pressure gradient; TCFA, thin cap fibroatheroma.

6. Clinical Outcomes according to PPG Index

Early studies highlighted the differential symptomatic response to PCI according to CAD patterns [42, 46]. Importantly, almost 1 in 4 patients remained symptomatic after PCI and this residual angina burden has been linked to worse prognosis, including cardiovascular mortality [43, 44, 45, 47, 48, 49]. These phenomenon were borne out using PPG index. A sub-analysis from the Trial of Angiography vs. pressure-Ratio-Guided Enhancement Techniques–Fractional Flow Reserve (TARGET-FFR) randomised clinical study included 107 patients who underwent baseline and follow up Seattle Angina Questionnaire (SAQ) to assess any difference in patient’s symptomatic status post PCI according to their CAD patterns [46, 50]. At baseline, the mean 7 items SAQ was comparable with no difference in the summary score among patients with focal versus diffuse CAD. Following PCI, patients with focal disease had significantly higher SAQ-7 summary score compared to patients with diffuse disease, with mean difference of 11.5 points [95% confidence interval (2.8 to 20.3), p = 0.01] [46, 50]. Such difference is of a very large magnitude when compared to the difference of merely 2.9 points in response to invasive revascularization on top of medical therapy in the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial [47, 51]. Furthermore, freedom from angina was more frequent in patients with focal compared to diffuse disease (27.5% vs 51.9%; p = 0.020) [46, 50]. Remarkably, more than half of the patients with diffuse disease remained symptomatic despite receiving longer and more stents [46, 50]. Overall, PPG index may be used to guide clinicians as well as patients with regards to symptomatic benefits prior to performing PCI.

Data from Mizukami et al. [35] highlighted the difference in procedural outcomes according to PPG-defined CAD patterns [31]. Using OCT, the authors reported that patients with diffuse disease had significantly smaller stent area as well as smaller distal reference lumen area [31, 35]. Notably, the proximal reference lumen area was comparable between patients with focal versus diffuse disease, highlighting the current challenges in percutaneously revascularizing the latter group [31, 35]. Like the data from Collet et al. [50] the number and length of stents were larger in patients with diffuse disease which translated into higher post procedural cardiac biomarkers compared to patients with focal disease [35]. Moreover, the number of stent edge dissection was numerically more frequent in patients with diffuse compared to focal disease [10 (15.4%) vs. 2 (5.4%), p = 0.24] [31, 35].

Beyond procedural outcomes, PPG index was also shown to predict target vessel failure. At 2 years, the incidence of target vessel failure was more frequent in patients with diffuse disease compared to focal disease [48, 52]. It is important to highlight that the study by Shin et al. [52] calculated PPG index using quantitative flow ratio (QFR) [48]. QFR-derived PPG index is a well validated metric and has been highlighted as a useful adjunctive tool in performing coronary revascularization [53, 54]. Clinical outcome data using FFR-derived PPG index are currently studied in the PPG global registry and its results are eagerly awaited [51].

There are some limitations associated with the use of PPG and invasive ischemia assessment. Pressure derived FFR simulates relative coronary flow reserve but is not a direct measure or simulation of absolute coronary flow. FFR does not reflect or determine the size of left ventricle mass at risk, which is a major determinant of mortality risk and the likelihood of benefit from revascularization. While FFR is a major step toward physiologic severity beyond angiogram anatomy, it does not predict physiologic severity for patient selection for revascularization that improves survival probability. Whilst, PPG is considered the next substantial step in characterising CAD (focal versus diffuse), PPG remains limited as a pressure-based simulation of relative flow reserve and is subjected to the same limitations to FFR. Moreover, it might not be able to differentiate hyperemic pressure fall due to high coronary blood flow through mild diffuse CAD from flow limiting diffuse CAD. Finally, no trial of FFR, PPG or their anatomic simulations identifies patients for whom revascularization improves survival probability. In contrast, absolute rest and stress myocardial perfusion per pixel in mL/min/g, coronary flow reserve as their ratio and coronary flow capacity combing stress perfusion and CFR quantify artery specific size-severity of abnormalities that do predict sufficiently high mortality risk that is reduced by 54% to 43% after revascularization in large clinical cohorts followed over 10 years and in a randomized trial respectively [55, 56, 57, 58].

7. Conclusions

PPG index is a novel metric and an emerging tool that provide quantitative measure on the focality or diffuseness of CAD. It provides a precise description of the longitudinal distribution of atherosclerotic plaque and enables clinicians to predict symptomatic response, residual ischemia, and potentially target vessel failure in patients undergoing percutaneous revascularization.

Acknowledgment

Not applicable.

Author Contributions

Conceptualization: MA; Methodology: MO, MA; Resources: MO, AI, ME, AZ, MA; Writing—original draft preparation: MO, MA; Review and editing: all authors; Visualization: MO, AI, MA; Supervision: MA; Project administration: MO, MA; Funding acquisition: BB, TC, AB, IP, ME, AZ, MF, MA. All authors contribute to the design of the work. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

Not applicable.

Funding

This research received no external funding.

Conflict of Interest

The authors declare no conflict of interest.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

[1] Neumann FJ Sousa-Uva M Ahlsson A Alfonso F Banning AP Benedetto U et al 2018 ESC/EACTS Guidelines on myocardial revascularization European Heart Journal 2019 40 87 165 30165437
[2] Tonino PAL Fearon WF De Bruyne B Oldroyd KG Leesar MA Ver Lee PN et al Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation Journal of the American College of Cardiology 2010 55 2816 2821 20579537
[3] Tonino PAL De Bruyne B Pijls NHJ Siebert U Ikeno F van’ t Veer M et al Fractional flow reserve versus angiography for guiding percutaneous coronary intervention The New England Journal of Medicine 2009 360 213 224 19144937
[4] De Bruyne B Pijls NHJ Kalesan B Barbato E Tonino PAL Piroth Z et al Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease The New England Journal of Medicine 2012 367 991 1001 22924638
[5] Davies JE Sen S Dehbi HM Al-Lamee R Petraco R Nijjer SS et al Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI The New England Journal of Medicine 2017 376 1824 1834 28317458
[6] Götberg M Christiansen EH Gudmundsdottir IJ Sandhall L Danielewicz M Jakobsen L et al Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI The New England Journal of Medicine 2017 376 1813 1823 28317438
[7] Xu B Tu S Song L Jin Z Yu B Fu G et al Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial Lancet (London, England) 2021 398 2149 2159 34742368
[8] Layland J Oldroyd KG Curzen N Sood A Balachandran K Das R et al Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial European Heart Journal 2015 36 100 111 25179764
[9] Kobayashi Y Tonino PAL De Bruyne B Yang HM Lim HS Pijls NHJ et al The impact of left ventricular ejection fraction on fractional flow reserve: Insights from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) trial International Journal of Cardiology 2016 204 206 210 26670174
[10] Alkhalil M McCune C McClenaghan L Mailey J Collins P Kearney A et al Comparative Analysis of the Effect of Renal Function on the Spectrum of Coronary Artery Disease The American Journal of Medicine 2020 133 e631 e640 32389657
[11] Alkhalil M McCune C McClenaghan L Mailey J Collins P Kearney A et al Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Diabetic Patients Cardiovascular Revascularization Medicine: Including Molecular Interventions 2020 21 897 902 31883978
[12] Alkhalil M Thomas G Spence MS Owens C McKavanagh P Sex-based difference in fractional flow reserve and its impact on clinical outcomes American Heart Journal 2021 242 24 32 34450050
[13] Lee JM Kim HK Park KH Choo EH Kim CJ Lee SH et al Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial European Heart Journal 2023 44 473 484 36540034
[14] Kim HL Koo BK Nam CW Doh JH Kim JH Yang HM et al Clinical and physiological outcomes of fractional flow reserve-guided percutaneous coronary intervention in patients with serial stenoses within one coronary artery JACC. Cardiovascular Interventions 2012 5 1013 1018 23078728
[15] Kimura Y Tanaka N Okura H Yoshida K Akabane M Takayama T et al Characterization of real-world patients with low fractional flow reserve immediately after drug-eluting stents implantation Cardiovascular Intervention and Therapeutics 2016 31 29 37 26135607
[16] De Bruyne B Pijls NH Heyndrickx GR Hodeige D Kirkeeide R Gould KL Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation Circulation 2000 101 1840 1847 10769286
[17] Pijls NH De Bruyne B Bech GJ Liistro F Heyndrickx GR Bonnier HJ et al Coronary pressure measurement to assess the hemodynamic significance of serial stenoses within one coronary artery: validation in humans Circulation 2000 102 2371 2377 11067791
[18] Hakeem A Uretsky BF Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes Circulation 2019 139 694 706 30689413
[19] Gould KL Lipscomb K Hamilton GW Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve The American Journal of Cardiology 1974 33 87 94 4808557
[20] Modi BN Sankaran S Kim HJ Ellis H Rogers C Taylor CA et al Predicting the Physiological Effect of Revascularization in Serially Diseased Coronary Arteries Circulation. Cardiovascular Interventions 2019 12 e007577 30722688
[21] Collet C Sonck J Vandeloo B Mizukami T Roosens B Lochy S et al Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis Journal of the American College of Cardiology 2019 74 1772 1784 31582137
[22] Mintz GS Popma JJ Pichard AD Kent KM Satler LF Chuang YC et al Limitations of angiography in the assessment of plaque distribution in coronary artery disease: a systematic study of target lesion eccentricity in 1446 lesions Circulation 1996 93 924 931 8598083
[23] Butler J Shapiro M Reiber J Sheth T Ferencik M Kurtz EG et al Extent and distribution of coronary artery disease: a comparative study of invasive versus noninvasive angiography with computed angiography American Heart Journal 2007 153 378 384 17307416
[24] Mintz GS Painter JA Pichard AD Kent KM Satler LF Popma JJ et al Atherosclerosis in angiographically “normal” coronary artery reference segments: an intravascular ultrasound study with clinical correlations Journal of the American College of Cardiology 1995 25 1479 1485 7759694
[25] Dourado LOC Bittencourt MS Pereira AC Poppi NT Dallan LAO Krieger JE et al Coronary Artery Bypass Surgery in Diffuse Advanced Coronary Artery Disease: 1-Year Clinical and Angiographic Results The Thoracic and Cardiovascular Surgeon 2018 66 477 482 28355655
[26] Baranauskas A Peace A Kibarskis A Shannon J Abraitis V Bajoras V et al FFR result post PCI is suboptimal in long diffuse coronary artery disease EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2016 12 1473 1480 27998839
[27] Shiono Y Kubo T Honda K Katayama Y Aoki H Satogami K et al Impact of functional focal versus diffuse coronary artery disease on bypass graft patency International Journal of Cardiology 2016 222 16 21 27448699
[28] Pijls NH De Bruyne B Peels K Van Der Voort PH Bonnier HJ Bartunek J Koolen JJ et al Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses The New England Journal of Medicine 1996 334 1703 1708 8637515
[29] De Bruyne B Hersbach F Pijls NH Bartunek J Bech JW Heyndrickx GR et al Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “Normal” coronary angiography Circulation 2001 104 2401 2406 11705815
[30] Gould KL Pressure-flow characteristics of coronary stenoses in unsedated dogs at rest and during coronary vasodilation Circulation Research 1978 43 242 253 668056
[31] Gould KL Nakagawa Y Nakagawa K Sdringola S Hess MJ Haynie M et al Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography Circulation 2000 101 1931 1939 10779459
[32] Candreva A Mizukami T Sonck J Munhoz D Nagumo S Di Gioia G et al Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions 2021 98 E647 E654 34264014
[33] Sonck J Mizukami T Johnson NP Nagumo S Gallinoro E Candreva A et al Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography & Interventions 2022 99 1518 1525 35233906
[34] Ohashi H Collison D Mizukami T Didagelos M Sakai K Aetesam-Ur-Rahman M et al Fractional Flow Reserve-Guided Stent Optimisation in Focal and Diffuse Coronary Artery Disease Diagnostics (Basel, Switzerland) 2023 13 2612 37568975
[35] Mizukami T Sonck J Sakai K Ko B Maeng M Otake H et al Procedural Outcomes After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease Journal of the American Heart Association 2022 11 e026960 36444858
[36] Scarsini R Fezzi S Leone AM De Maria GL Pighi M Marcoli M et al Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions JACC. Cardiovascular Interventions 2022 15 2174 2191 36357022
[37] Wolfrum M De Maria GL Benenati S Langrish J Lucking AJ Channon KM et al What are the causes of a suboptimal FFR after coronary stent deployment? Insights from a consecutive series using OCT imaging EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2018 14 e1324 e1331 29784630
[38] Fournier S Ciccarelli G Toth GG Milkas A Xaplanteris P Tonino PAL et al Association of Improvement in Fractional Flow Reserve With Outcomes, Including Symptomatic Relief, After Percutaneous Coronary Intervention JAMA Cardiology 2019 4 370 374 30840026
[39] Kwak BR Bäck M Bochaton-Piallat ML Caligiuri G Daemen MJAP Davies PF et al Biomechanical factors in atherosclerosis: mechanisms and clinical implications European Heart Journal 2014 35 3013 3020, 3020a 25230814
[40] Wentzel JJ Janssen E Vos J Schuurbiers JCH Krams R Serruys PW et al Extension of increased atherosclerotic wall thickness into high shear stress regions is associated with loss of compensatory remodeling Circulation 2003 108 17 23 12821552
[41] Chatzizisis YS Coskun AU Jonas M Edelman ER Feldman CL Stone PH Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior Journal of the American College of Cardiology 2007 49 2379 2393 17599600
[42] Matsuo Y Higashioka D Ino Y Shiono Y Kitabata H Terada K et al Association of Hemodynamic Severity with Plaque Vulnerability and Complexity of Coronary Artery Stenosis: A Combined Optical Coherence Tomography and Fractional Flow Reserve Study JACC. Cardiovascular Imaging 2019 12 1103 1105 30660534
[43] Driessen RS de Waard GA Stuijfzand WJ Raijmakers PG Danad I Bom MJ et al Adverse Plaque Characteristics Relate More Strongly with Hyperemic Fractional Flow Reserve and Instantaneous Wave-Free Ratio Than with Resting Instantaneous Wave-Free Ratio JACC. Cardiovascular Imaging 2020 13 746 756 31422133
[44] Sakai K Mizukami T Leipsic J Belmonte M Sonck J Nørgaard BL et al Coronary Atherosclerosis Phenotypes in Focal and Diffuse Disease JACC. Cardiovascular Imaging 2023 16 1452 1464 37480908
[45] Candreva A Gallo D Munhoz D Rizzini ML Mizukami T Seki R et al Influence of intracoronary hemodynamic forces on atherosclerotic plaque phenotypes International Journal of Cardiology 2024 399 131668 38141723
[46] Ando H Takashima H Suzuki A Sakurai S Kumagai S Kurita A et al Impact of lesion characteristics on the prediction of optimal poststent fractional flow reserve American Heart Journal 2016 182 119 124 27914491
[47] Venkitachalam L Kip KE Mulukutla SR Selzer F Laskey W Slater J et al Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry Circulation. Cardiovascular Quality and Outcomes 2009 2 607 615 20031899
[48] Shaw LJ Berman DS Maron DJ Mancini GBJ Hayes SW Hartigan PM et al Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy Circulation 2008 117 1283 1291 18268144
[49] Mozaffarian D Bryson CL Spertus JA McDonell MB Fihn SD Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease American Heart Journal 2003 146 1015 1022 14660993
[50] Collet C Collison D Mizukami T McCartney P Sonck J Ford T et al Differential Improvement in Angina and Health-Related Quality of Life After PCI in Focal and Diffuse Coronary Artery Disease JACC. Cardiovascular Interventions 2022 15 2506 2518 36543445
[51] Spertus JA Jones PG Maron DJ O’Brien SM Reynolds HR Rosenberg Y et al Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease The New England Journal of Medicine 2020 382 1408 1419 32227753
[52] Shin D Dai N Lee SH Choi KH Lefieux A Molony D et al Physiological Distribution and Local Severity of Coronary Artery Disease and Outcomes After Percutaneous Coronary Intervention JACC. Cardiovascular Interventions 2021 14 1771 1785 34412795
[53] Dai N Hwang D Lee JM Zhang J Jeon KH Paeng JC et al Feasibility of Quantitative Flow Ratio-Derived Pullback Pressure Gradient Index and Its Impact on Diagnostic Performance JACC. Cardiovascular Interventions 2021 14 353 355 33541549
[54] Dai N Yuan S Dou K Zhang R Hu N He J et al Prognostic Implications of Prestent Pullback Pressure Gradient and Poststent Quantitative Flow Ratio in Patients Undergoing Percutaneous Coronary Intervention Journal of the American Heart Association 2022 11 e024903 35656982
[55] Munhoz D Collet C Mizukami T Yong A Leone AM Eftekhari A et al Rationale and design of the pullback pressure gradient (PPG) global registry American Heart Journal 2023 265 170 179 37611857
[56] Gould KL Nguyen T Kirkeeide R Roby AE Bui L Kitkungvan D et al Subendocardial and Transmural Myocardial Ischemia: Clinical Characteristics, Prevalence, and Outcomes with and Without Revascularization JACC. Cardiovascular Imaging 2023 16 78 94 36599572
[57] Gould KL Kitkungvan D Johnson NP Nguyen T Kirkeeide R Bui L et al Mortality Prediction by Quantitative PET Perfusion Expressed as Coronary Flow Capacity with and Without Revascularization JACC. Cardiovascular Imaging 2021 14 1020 1034 33221205
[58] Gould KL Johnson NP Roby AE Nguyen T Kirkeeide R Haynie M et al Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 2019 60 410 417 30115688
